ArticleCancer management and research2025
Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances.
Article in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Scalp cooling has emerged as a promising intervention for mitigating chemotherapy-induced alopecia, particularly in patients undergoing anthracycline- and taxane-based regimens typically associated with complete hair loss. Despite a visible hair retention rate of 53%, efficacy varies significantly among individuals, influenced by modifiable factors including general health, hair follicle characteristics, and treatment protocols. Methods: This study evaluated 81 breast cancer patients treated with Epirubicin/Cyclophosphamide followed by weekly Paclitaxel application. Hair preservation was assessed using a cross-section trichometer (Cohen Hair Mass Index [HMI]), light microscopy, and scanning electron microscopy. Key parameters evaluated included pre- and posttherapeutic trichological characteristics such as bulb diameter, shaft diameter, anagen rate, as well as grade of hair shaft damage. Results: A total of 53% of patients retained visible hair post-treatment (HMI ≥ 50). Trichological factors-particularly bulb diameter, shaft diameter, and anagen rate-strongly predicted hair preservation outcomes. Additionally, hair shaft integrity, specifically surface damage grading, emerged as a critical determinant of clinically meaningful hair retention. Conclusion: Scalp cooling's protective effect extends beyond aesthetics, significantly supporting psychological well-being during cancer treatment. Emerging strategies, including cell cycle modulation, antioxidant-based treatments, offer promising avenues to enhance follicular and shaft resilience. While these require further clinical validation, the findings highlight the potential to improve scalp cooling outcomes and raise the standard of supportive oncologic care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.